{"text": "TITLE:\n      The Effect of Anticholinergics on Cognitive Function in the Elderly\nSUMMARY:\n      Anticholinergic medication is used to treat overactive bladder (OAB). A known side effect of\n      this medication is cognitive dysfunction. OAB is more prevalent in the elderly population -\n      a group that also has a higher baseline risk of cognitive dysfunction. Our objective is to\n      evaluate the effect of an anticholinergic medication on cognitive function in elderly women.\n      Subjects will be randomized to:1) trospium chloride or 2) placebo. There are three aims: 1)\n      To evaluate changes in cognitive function in elderly women taking trospium versus placebo,\n      using validated cognitive assessment tests. 2) To develop a useful battery of cognitive\n      screening tests for monitoring the cognitive safety of OAB management. 3) To understand how\n      the timing of cognitive changes relates to the timing of improvement in OAB symptoms. The\n      investigators will recruit 60 women aged \u2265 50 with the diagnosis of OAB. Cognitive\n      assessments will be performed at baseline and Week 1 and 4 after drug initiation using\n      paper-based validated questionnaires. OAB improvement will be assessed with validated\n      questionnaires.\nELIGIBILITY CRITERIA:\n      Inclusion Criteria:\n          -  Female 50 or older\n          -  Diagnosis of OAB (ICS definition)\n          -  English literacy\n          -  Ability to swallow oral medication\n          -  Cognitive ability to give consent\n        Exclusion Criteria:\n          -  Dementia/Depression/Delirium\n          -  Current anticholinergic use (requires 2 week washout period)\n          -  Current cholinesterase\n          -  Urinary or gastric retention\n          -  Severe decreased gastrointestinal motility\n          -  Uncontrolled narrow-angle glaucoma\n          -  Myasthenia gravis\n          -  Diagnosis fo renal impairment (creatinine clearance <30 mL/min)\n", "cuis": "C0009240 C4050130 C0392334 C3641649 C0242896 C3537307 C3540711 C3537004 C0242893 C1552616 C1706244 C0878773 C0242896 C3537004 C3537307 C3540711 C0879626 C0013227 C2081612 C2094204 C0033045 C1971835 C0802604 C2598133 C3845898 C0338656 C0013227 C2081612 C2094204 C0033045 C1971835 C0802604 C2598133 C0338656 C0018017 C2239270 C2979883 C1552839 C0728774 C0392335 C2237115 C0392334 C2237374 C0242896 C3537004 C3537307 C3540711 C0013227 C2081612 C2094204 C0033045 C1971835 C0802604 C2598133 C0220825 C0077408 C1132856 C2710902 C2710904 C0032042 C1328018 C0392335 C2237115 C0392334 C2237374 C0772089 C0032042 C0220825 C0870300 C0542351 C1555716 C0392366 C3850116 C2363670 C0871311 C0459958 C0373483 C0150369 C1283169 C0026426 C0182230 C0376636 C0162340 C1457887 C1392786 C3844714 C0011900 C0945731 C0551521 C0552426 C0560182 C0686906 C0679838 C1261322 C0031809 C0220825 C0870300 C0589507 C0013227 C1254351 C0728774 C0034394 C1706422 C3836256 C3836250 C3836251 C3836252 C3836254 C3836255 C3844714 C0034394 C1706422 C3836256 C3836250 C3836251 C3836252 C3836254 C3836255 C0243161 C0013893 C0243161 C3843698 C3843778 C1704788 C3539107 C0011900 C0945731 C3540738 C0020899 C0566355 C0221470 C4048182 C0566358 C0566363 C0175795 C0392334 C0243161 C0011570 C0011581 C1999266 C4049644 C0344315 C0812393 C1579931 C0035143 C0520887 C2121458 C0497327 C0011265 C0011206 C0242896 C3537004 C3537307 C3540711 C0025344 C1561540 C3245501 C3245502 C0202207 C0008425 C0373578 C1867467 C3540712 C0585136 C0678835 C0007608 C1510470 C1547227 C1547231 C1561581 C4050465 C4050466 C0264097 C2707256 C0596601 C0809794 C0017173 C0184122 C0687713 C0920703 C0017181 C0017185 C0203054 C0237938 C0436865 C0744333 C0849766 C1141929 C2697368 C0032827 C0162119 C0239787 C0520831 C0520870 C0728725 C1295611 C1295666 C1295669 C0017605 C0857250 C0026896 C0373595 C0812399 C1565489 C1565662 C0011900 C0945731 ", "concepts": "Cognitive Functions, Cognitive Function, Cognitive Functioning, FACT-Cognitive Function, anticholinergics, Anticholinergics, Anticholinergics, Anticholinergic, cholinergics summary, summary overactive bladder, anticholinergics, Anticholinergic, Anticholinergics, Anticholinergics, side effect, Medications, medication:, medications:, Premedication, IV medication, Medications, Medications, Uknown cognitive dysfunction, Medications, medication:, medications:, Premedication, IV medication, Medications, Medications cognitive dysfunction, Objective, objective, Objective, groups, Vaseline Cognitive functioning, cognitive functions, cognitive functioning, no cognitive function, anticholinergic drug, Anticholinergic, Anticholinergics, Anticholinergics, Medications, medication:, medications:, Premedication, IV medication, Medications, Medications, Evaluate trospium chloride, trospium chloride 2 MG, trospium chloride 20 MG, trospium chloride 60 MG, placebo, Therex Cognitive functioning, cognitive functions, cognitive functioning, no cognitive function, trospium, placebo, Evaluate cognitive assessment, battery, battery, tests, Etests, developer screening tests, HIV screening tests, drug screening tests, monitoring, Monitoring, monitoring BP, monitoring ph, management, understand symptoms, Cognitive changes, No improvement diagnosis, Diagnosis, ED diagnosis, ED diagnosis, no diagnosis, No diagnosis, Misdiagnosis assessment, Assessment, Assessment, Assessment, initiation, drug, drug, Vaseline questionnaires, Questionnaires, questionnaires ad8, questionnaires moca, questionnaires koos, questionnaires kccq, questionnaires hoos, questionnaires bomc, No improvement questionnaires, Questionnaires, questionnaires ad8, questionnaires moca, questionnaires koos, questionnaires kccq, questionnaires hoos, questionnaires bomc criteria, Eligibility Criteria 60 or older, 70 or older definition, Definition, {Diagnosis}, Diagnosis English, Illiteracy Ability to swallow, Inability to swallow, inability to swallow, Ability to swallow food, Ability to swallow fluid, oral medication Cognitive ability Criteria depression, -- Depression, Depression, Depression, depression, depression, depression, Repression, ST Depression, PR Depression, Dementias, dementia, Delirium anticholinergic drug, Anticholinergic, Anticholinergics, Anticholinergics, period, week, required, required cholinesterase test, anticholinesterases, cholinesterase; rbc, Acholinesterasemia, Anticholinesterases gastric retention Motility, Motility, Motility, Severe, Severe, Severe, Severe, Severe, Sever, Gastrointestinal, gastrointestinal gas, gastrointestines, gastrointestinal agent, gastrointestinal tubes, gastrointestinal pains, gastrointestinal sign, gastrointestinal bleed, gastrointestinal tumor, X-ray gastrointestinal, Ulcer gastrointestinal, O/E - gastrointestinal, gastrointestinal polyp, gastrointestinal colic, edema gastrointestinal, Upset gastrointestinal, K+ decreased, Hb decreased, GH decreased, VC decreased, CI decreased, pH decreased, LH decreased, T4 decreased, T3 decreased narrow-angle glaucoma, Uncontrolled INR Myasthenia gravis creatinine clearance test, Creatinine clearance, renal impairment, Acute renal impairment, {Diagnosis}, Diagnosis "}
